Meteoric Resources’ high-grade rare earths results
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the Caldeira rare earth ionic clay project in Brazil from Meteoric Resources.
News
LTR Pharma celebrates online access for ED spray
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the online healthcare platform to access erectile dysfunction treatment from LTR Pharma.
M&A on the cards as cash slows
Mergers and acquisitions are on the agenda for explorers in 2025, with new figures showing how cash is drying up for small miners.
The first battery metal to rebound
Chinese export controls have thrown graphite back into the spotlight, with experts liking its long term outlook.
How many Carlow Castles can Artemis find?
Artemis Resources is taking inspiration from De Grey’s Hemi, hunting for repeats of its 704,000oz gold equivalent Carlow Castle deposit in the Pilbara.
ASX uranium plays claim unwanted title
Drumroll… uranium play Paladin Energy is the most shorted stock on the ASX, while Boss Energy is second.
Tech stocks dip as traders await US CPI data
ASX tech stocks continued to slide on hump day, while gold rebounded ahead of US CPI data and South32 dropped on Mozambique unrest.
This fundie caught the gold boom early
A pivot to gold miners ahead of this year’s bullion boom has led to positive returns for Stephen Gorenstein at the Ari Fund.
ASX juniors are drilling hard into Xmas
In spite of market challenges, these small-cap resources companies have remained steadfast in their exploration and drilling goals.
Pharma/chemist union turns heads
Morgans healthcare analyst Scott Power had his eyes on Sigma Healthcare this week, which soared after the ACCC approves its merger with Chemist Warehouse.
Silex Systems uranium tech in the draw for US billions
Sarah Hughan unfurls the Silex Systems selection as a uranium enrichment awardee by the US Department of Energy.
Sunshine’s substantial expansion
Sarah Hughan reveals all on a Sunshine Metals upgrade which placed Ravenswood Consolidated as one of Queensland’s larger undeveloped gold and base metals projects.
ASX slips, S32 tumbles amid Mozambique unrest
South32 has dropped on Wednesday on Mozambique unrest, while Chemist Warehouse plans an ASX listing after merging with Sigma.
The race is on for the next blood-cancer drugs
Syntara hopes to emulate the success of Ojjaara, a $2.6 billion home-grown myelofibrosis therapy approved in the US.
Is nuclear energy more eco-friendly than renewables?
Research firm Goehring & Rozencwajg believes nuclear energy trumps the green credentials of renewables thanks to small modular reactors.
Navarre heads back to its roots
$10 million capped Victorian gold explorer Navarre Minerals is getting ready to drill as the revived junior heads back to its roots.
FireFly lights up on copper hit
Steve Parsons’ FireFly Metals was the toast of the town on Tuesday with high-grade copper hits at its Green Bay project in Canada.
ASX pares losses as RBA eases rate-hike tone
The RBA held rates at 4.35pc, with the ASX paring losses as mining stocks rose and tech shares fell after China’s policy shift.
Desert Metals strikes gold at King Kong prospect
Sarah Hughan divulges on Desert Metals’ drilling which confirmed potential to host a significant gold system in the underexplored greenstone of Cote d’Ivoire.
ASX dips as tech slump slows mining rally
The ASX200 has slipped a tad so far on Tuesday, despite a mining rally driven by China’s stimulus signals.
ReNerve’s exclusive Middle East agreement
Sarah Hughan reveals all on ReNerve’s exclusive distribution agreement for sales and marketing across the Middle East.
Some broker love for RAS Tech and Chrysos
RAS Technology has received a ‘buy’ rating with strong growth predicted, while Chrysos could disrupt mining with game-changing tech – according to these brokers.
Opyl launches ‘world’s first’ AI biotech fund
In a claimed world’s first, Opyl is parterning with L39 Capital to launch a fund using robots to select stocks.
Closing Bell: ASX ends Day of the Guzman flat as a tortilla; Terra soars on PGE reef news
The ASX200 has ended Thursday absolutely flat despite a sparkling debut from Guzman Y Gomez.
Rise and Shine: Everything you need to know before the ASX opens
Good morning, and Happy Friday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
CLOSING BELL: Thursday Jul 4, 2024
Miners rode the iron ore price higher, ASX up 1.19pc at close.
Rise and Shine: Everything you need to know before the ASX opens – 05 Jul 2024
Good morning! Here’s everything you need to know before the ASX opens today.
Could US graphite plays bridge looming supply gap?
The US is looking to its domestic graphite operations, with a forecast of 300 mines and $7.5bn needed to meet demand by 2035.
Election and Fed to drive market this week
The ASX is set to rise, with the upcoming election and Federal Reserve meeting. Amazon and Intel surged after reporting strong earnings.
ASX keeps eyeing fresh highs
The ASX hits a new high and nears 8,500, while oil prices surge amid the Ukraine-Russia conflict.
It’s a slow burn for this skin-regeneration player
Avita Medical’s approved spray-on skin burns treatment has the runs on the board. Now all it has to do is execute commercial rollout and show consistent profitability. Easy, right?
Pursuit Minerals’ achieves 339% resource upgrade
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the Rio Grande Sur lithium project in Argentina from Pursuit Minerals.
ASX flat as energy sector dips
The ASX finished flat on Monday, suppressed by weakening energy stocks. Meanwhile the Aussie dollar took a dip ahead of the RBA decision.
Break it Down: Infinity Mining
Break it Down investigates another Infinity Mining acquisition as the company continues to retool its portfolio.
Copper stock wins go to Infinity, and beyond!
Infinity shares rocket up on Cangai purchase, while White Cliff is on a heater with large-scale copper finds at Rae.
Dow Jones at record after blowout jobs report
The US added 254,000 jobs in September and unemployment dropped to 4.1%. With the Fed cutting rates, a soft landing looks likely.
Castillo Copper completes Harts Range acquisition
Today’s Break it Down details Castillo Copper’s new niobium, uranium, and heavy rare earths project in the NT.
Tech stocks rally; AZ9 soars 70%, Paladin drops
The ASX closed higher on gains in tech stocks, with Fortescue rising while Paladin Energy plummeted following acquisition warning.
Niobium dreams send Aldoro higher
Aldoro Resources has gained 250% in the past month, with niobium punters itching for drilling results from its Kameelburg project in Namibia.
Variscan Mines increases resource estimate threefold
Break it Down’s Sarah Hughan zooms in on the newly tripled zinc mineral resource estimate from Variscan Mines.
ASX slips as iron ore, energy, and ANZ fall
The ASX 200 has begun in sluggish fashion on Monday after Wall Street’s record high on Friday. ANZ has dipped on CEO news, while energy and iron ore sectors have fallen.
Sonic Healthcare seals $700m German deal
Global pathology and radiology provider Sonic has augmented a recent string of acquisitions with the circa $700 million purchase of a German provider.
How Trump changes landscape for investors
Chris Judd joins Stockhead for a special MoneyTalks on what Donald Trump’s election win could mean for investors.
Javelin looks to emulate Spartan’s golden success
They say the best place to look for gold is next to a mine, so that’s exactly the strategy of microcap explorer Javelin Minerals, writes Kristie Batten.
How the Santa rally keeps giving to the ASX
December brings the ‘Santa rally’, accounting for 29% of Aussie market gains – a smart time to stay invested?
Copper production goal for these companies
Junior companies with the right mix of resources, location and exploration potential are racing towards the line to be the next mid-tier ASX copper producer.
How to pick the next small-cap takeover target
M&A activity is hotting up across the board, with undervalued small to mid-caps stocks offering the best value.
Pay attention to ASX copper sleeper
ASX copper hopeful KGL Resources continues to fly under the radar, but Barry FitzGerald sees plenty of reasons to take a look.
Which ASX medtech soared 70pc this week?
Micro-X’s 70% climb this week proves momentum is returning to the ASX healthcare sector, notes Morgans analyst Scott Power.
Tony’s Takeaway: Summertime stocks
Tony Locantro looks ahead to the Summer of Tony and two stocks rounding the bend into a big finish as he looks ahead to 2025.
The upside in ASX gold miners
Gold equities are starting to catch up to the rapid rise in gold prices this year. RBC thinks there’s still plenty of upside.
ESG vs impact investing – what’s safer?
ESG investing is here to stay, but what’s the difference between ESG and impact investing, and is ESG a safer bet?
ASX and Bitcoin cool off; Iluka hit by costs
The ASX has dipped on Friday after a US pullback. Meanwhile Bitcoin has retreated from US$100k and Iluka has slumped on cost overrun news.
ASX struggles, Bitcoin dips after record highs
The ASX dipped on Friday ahead of (another) key US jobs report. Meanwhile Bitcoin cooled off, APA rose and Iluka slumped.
Niobium results are still fuelling Aldoro
Aldoro’s highly successful niobium exploration results at its Kameelburg project are still fuelling gains on the ASX.
Live Verdure leads AI into leadership
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing a new partnership for the AI business functions subsidiary from Live Verdure.
Iluka Resources gets $400M Gov assist
Sarah Hughan goes over the Australian government’s financial support for Iluka Resources’ rare earths refinery in this Break it Down.
Rio brings copper, lithium to fore
Rio Tinto remains bullish on copper and lithium despite short term headwinds and Iluka nabs Canberra rare earths funding.
Why AI should be on the radar of every investor
Nvidia’s latest earnings were an absolute knockout, but the real story isn’t just about the numbers, it’s about the revolution behind them, writes Nigel Green.
Deal shines light back on Canada lithium
A big merger in the Canadian lithium sector is shining a light back on ASX plays progressing quality projects.
Lepidico appoints administrators amid low lithium prices
Lithium player Lepidico has appointed administrators after failing to finance a planned African project.
Private equity is hot for copper
Cyprium has rejected a $53 million bid from PE firm Appian Capital Advisory, as the big end of town gets hot for copper mines.
ASX up on Thursday as Bitcoin surges again
ASX opens higher as Rio Tinto shifts focus to copper, and Bitcoin surges past US$100K.
Could Trump’s return boost psychedelics?
President-elect Donald Trump’s return to the White House might favourably impact the psychedelics sector with these ASX stocks in the spotlight.
ASX up, Lumos gets US approval, BTC moons
The ASX rose on Thursday thanks to a tech rally and Wall Street gains, while Bitcoin surged past US$100K.
ASX health stocks rise despite hot inflation
Morgans analyst Scott Power said ASX health stocks have risen this week despite release of hotter than expected inflation figures.
Wall Street recovers; Goldman sees 2025 recession risk
Despite a Wall Street rebound, the ASX is expected to drop on Wednesday, with Goldman predicting a 25% chance of a US recession in 2025.
Top 10 at 11: Fresh from the ASX today
Stockhead’s Top 10 at 11: a short, sharp update to help frame the trading day.
LBT soars after securing AstraZeneca deal
Biotech LBT Innovations says the deal opens up potential for further orders from AstraZeneca and other large pharmaceutical companies.
Energy, Real Estate stocks rebound as ASX rises
Dip buying is driving the ASX higher today as sold down sectors climbed on Wednesday.
All you need to know before the ASX opens
Here’s everything you need to know before the ASX opens today.
ASX health stocks dip, but recover
ASX health stocks regained ground on Friday but, at the time of publishing, fell by 0.37% overall. Yep, it’s been a volatile old week.
Forgotten biotech stocks soar
The biotech sector is fast emerging from its two-year funk amid a rush of news about clinical trials, approvals and capital raisings.
Gold’s M&A rush beyond De Grey
Argonaut’s Hayden Bairstow predicts more Australian gold M&A could be on the horizon, with mergers likely for single asset companies.
Fenix Resources’ 177% increase
Stockhead TV’s Sarah Hughan Breaks it Down on a new and improved mineral resource estimate from Fenix Resources.
DroneShield’s new $8.2M contract
Stockhead TV’s Sarah Hughan divulges on an $8.2M European military agency order for DroneShield defence technology.
Things are looking up right now for Singular Health
This ASX medtech appears to have a singularly healthy prognosis. Steve Collette analyses.
Critical minerals stocks surge on China ban
China has escalated a trade war with the US, suspending gallium, germanium and antimony exports. That’s another tailwind for ASX stocks.
Mining’s top dogs predict the future
Kristie Batten chats with mining bigwigs Bill Beament and Simon Lawson on Trump’s impact on miners, gold M&A and more.
Is it time for this cancer-targeting biotech to soar?
Oncosil Medical’s investors have been promised a “catalyst rich” 2025 and 2026, including expected TGA filings in early 2025.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/15